Last reviewed · How we verify
NCT04423484: GFANEPHRO20
Therapeutic Recommendations for Nephroblastoma
trial testing Data collection in Nephroblastoma in 1,000 participants. Currently enrolling.
31 December 2028
Quick facts
| Lead sponsor | French Africa Pediatric Oncology Group |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 July 2020 |
| Primary completion | 31 December 2028 |
| Estimated completion | 30 December 2030 |
| Sites | 7 locations across Senegal, Mali, Burkina Faso, Democratic Republic of the Congo, Madagascar, Côte d’Ivoire |
Drugs / interventions tested
- Data collection — full drug profile →
Conditions studied
- Nephroblastoma — all drugs for Nephroblastoma →
Sponsor
French Africa Pediatric Oncology Group
Who can join
Adults 6 Months to 18, any sex, with Nephroblastoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04423484
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Data collection
Trials testing the same drug.
- NCT07010562 — A Multi-site, Pre-clinical, Prospective Data Collection Study in Patients Undergoing a Right Heart Catheterization · not yet recruiting
- NCT07418359 — Comparison of Patient's Physical Activity Levels According to the Physical Activity Level of Their General Practitioner · recruiting
- NCT07197398 — Preoperative Data and the Spinal Spread of Local Anesthetic in Cesarean Section · recruiting
- NCT06998797 — Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study · not yet recruiting
- NCT07529730 — Outcomes of Surgical Treatment in Patients With Infective Endocarditis · completed
Other recruiting trials for Nephroblastoma
Currently open trials in the same condition.
- NCT05985161 — A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors · Phase 2 · recruiting
Other French Africa Pediatric Oncology Group trials
Trials by the same sponsor.
- NCT05407480 — Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma · recruiting
- NCT04794296 — Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP · recruiting
- NCT04425421 — Recommendations for the Treatment of Children With Burkitt's Lymphoma · recruiting
- NCT04425434 — Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04423484 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by French Africa Pediatric Oncology Group
- Last refreshed: 2 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04423484.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing